Disease trajectories in Atopic Dermatitis and Psoriasis

Disease trajectories in Atopic Dermatitis and Psoriasis - DiTrAP

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00013504

Enrollment

300

Registered

2019-07-12

Start date

2018-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L40.0 L20.8

Interventions

Group 1: Longitudinal Observation of all qualifiing patients with biosampling und documentation of clinical aspects. Severityindices (EASI, SCORAD, IGA) will be documented as well as Patient related o

Eligibility

Sex/Gender

All

Age

0 Years to 100 Years

Inclusion criteria

Inclusion criteria: Diagnosis of atopic dermatitis or psoriasis

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Primary Endpoint: EASI after 10 years of observatoinal period.	—

Secondary

Measure	Time frame
Descriptive Analysis at the end of the 10 year obersvational period of: - Development of Comorbidity - Changes in therapy - Changes in microbiota - Changes in epigenome	—

Countries

Germany

Contacts

Public ContactSascha Gerdes

Klinik für Dermatologie, UKSH Campus Kiel

sgerdes@dermatology.uni-kiel.de0431 500 21151

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026